Explore comprehensive lifetime management strategies for aortic stenosis with Dr Samineh Sehatbakhsh, addressing the evolving landscape of treatment options for patients across all risk categories.
This detailed presentation, part of the Complex Cases track, examines the critical decision-making process between TAVR and surgical aortic valve replacement in the modern era. Dr Sehatbakhsh addresses the expanding indications for TAVR, including recent approval for asymptomatic severe aortic stenosis, and the implications for lifetime management strategies in younger, low-risk patients.
Dr Sehatbakhsh provides practical insights into interpreting recent trial data comparing balloon-expandable and self-expanding valves, highlighting considerations such as patient-prosthesis mismatch, pacemaker requirements, and bioprosthetic valve dysfunction.
The discussion emphasizes the importance of comprehensive pre-procedural planning using advanced CT imaging to assess anatomical feasibility, coronary obstruction risk, and optimal valve sizing. Special attention is given to challenging scenarios including bicuspid aortic stenosis, small annulus considerations, and the unique challenges of paravalvular leak prevention.
About Women As One
Women As One is a global organization dedicated to empowering women in cardiology. They offer a variety of resources and programs, including the CLIMB® 2025 Skills Training Program and the Women As One Talent Directory, a global community of women in cardiology.
Join the Women As One Community
Women physicians who are not yet part of the Women As One community can register for free here.
Comments